Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced that its research has been featured on the cover of RSC Sustainability, ...

By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...

Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating durable positive brain biochemical ...

Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough advancement in its proprietary enzyme development ...

Microbiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept grant to further develop a promising CRISPR-based approach to cancer treatment. With ...

Denali will sponsor a satellite symposium event titled “Transforming Patient Care in MPS II” on Thursday, February 5, 2026, ...

Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...

About Chiesi Group Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative ...

Finding a set-in stain on a favorite shirt is not fun. The heat of a dryer often acts like a permanent seal, bonding oils and pigments deep into the fabric fibers in a way that seems impossible to ...

Recent studies have examined the effects of non-thermal processing on phenolics, flavonoids, anthocyanins, vitamins and overall antioxidant capacity across a range of food matrices. Compared with ...

Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) ...

Ultragenyx now expects a 6-month review period for the therapy and a likely decision from the FDA regarding potential ...